Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	463668.85	133554.86	-28.80
Graham Fair Price	-52.72	3648.32	7716.68
PEG	778.75	0.13	-0.01
Price/Book	-20.49	3.54	4.45
Price/Cash Flow	8.39	-13.33	-14.55
Prices/Earnings	-188.91	-9.45	-3.27
Price/Sales	-8.84	1.55	1.70
Price/FCF	8.39	-13.33	-14.55
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	511.62	0.04	< 0.005
Operating Margin	90.91	-0.01	-0.11
ROA	74.34	-0.01	-0.05
ROE	-0.34	-0.09	72.48
ROIC	-0.06	< 0.005	92.48
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.01	-0.07	82.63
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-3.65	0.93	-74.58
EPS QOQ	-2.29	0.75	-67.12
FCF QOQ	-1.94	0.22	-88.79
Revenue QOQ	0.30	-0.21	-29.04
Naive Interpretation	member

03 - Financial Growth · Bad

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	25.58	34.04	33.05
Days Sales Outstanding (DSO)	53.70	63.61	18.47
Inventory Turnover	3.52	2.64	-24.84
Debt/Capitalization	0.78	0.80	1.95
Quick Ratio	0.52	0.49	-5.90
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	2789.15	2513.62	-9.88
Cash	2284.15	1980.15	-13.31
Capex	-46.51	-30.73	33.93
Free Cash Flow	-853.42	-667.59	21.77
Revenue	7300.83	5738.89	-21.39
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.81	0.78	-3.85
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-11.87	64624.25	544514.65
Naive Interpretation	Member

06 - Financial Health · Bad

Rating